Earnings Results: Moderna stock falls after earnings miss by a wide margin and company cuts sales outlook by up to $3 billion

Moderna Inc. shares moved lower Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter earnings and lowered full-year sales guidance by up to $3 billion.